Overview
Andreas Kaubisch is an Oncologist in Bronx, New York. Dr. Kaubisch is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Liver Cancer, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), and Ampullary Cancer.
His clinical research consists of co-authoring 30 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
111 E 210th St, Bronx, NY 10467
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Trustees Of Columbia University In The City Of New York
Antonio Fojo is an Oncologist in New York, New York. Dr. Fojo is rated as a Distinguished provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Neuroendocrine Tumor, Pheochromocytoma, Adrenal Cancer, and Adrenocortical Carcinoma.
Yale University
Hari Deshpande is an Interventional Cardiologist and an Oncologist in New Haven, Connecticut. Dr. Deshpande is rated as a Distinguished provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Desmoid Tumor, Liposarcoma, Alveolar Soft Part Sarcoma, and Gastrostomy.
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
Vincent Vinciguerra, MD, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Vinciguerra specializes in treating gastrointestinal cancers and breast cancer. As an attending physician at the Monter Cancer Center, Dr. Vinciguerra focuses on providing compassionate, personalized, and evidence-based care. He also has devoted his career to Cancer Control and Prevention programs. He is the principal investigator for the National Cancer Institute (NCI) supported National Community Oncology Research Program which offers clinical trials and innovative therapies for cancer patients. Dr. Vinciguerra has published over 100 journal articles on cancer drug trials and treatments related to his national and international collaborations. Dr. Vinciguerra earned his medical degree and trained in internal medicine at the Georgetown University Medical Center. He completed training in Hematology/Oncology at New York Hospital. Dr. Vinciguerra is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Vinciguerra is rated as a Distinguished provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Familial Colorectal Cancer, and Colorectal Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Liver CancerDr. Kaubisch isElite. Learn about Liver Cancer.
- Distinguished
- Ampullary CancerDr. Kaubisch isDistinguished. Learn about Ampullary Cancer.
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Kaubisch isDistinguished. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- Fibrolamellar CarcinomaDr. Kaubisch isDistinguished. Learn about Fibrolamellar Carcinoma.
- Advanced
- Colorectal CancerDr. Kaubisch isAdvanced. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Kaubisch isAdvanced. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Kaubisch isAdvanced. Learn about Familial Pancreatic Cancer.
- Gallbladder AdenocarcinomaDr. Kaubisch isAdvanced. Learn about Gallbladder Adenocarcinoma.
- Gallbladder CancerDr. Kaubisch isAdvanced. Learn about Gallbladder Cancer.
- Neuroendocrine TumorDr. Kaubisch isAdvanced. Learn about Neuroendocrine Tumor.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Kaubisch isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with MaturationDr. Kaubisch isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Kaubisch isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adrenal CancerDr. Kaubisch isExperienced. Learn about Adrenal Cancer.
- AgranulocytosisDr. Kaubisch isExperienced. Learn about Agranulocytosis.
